[{"indications": "Indications\u00a0to extend life in patients with amyotrophic lateral sclerosis, initiated\r\nby specialists experienced in the management of motor neurone disease", "name": "RILUZOLE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.9 Drugs used in parkinsonism and related disorders", "4.9.3 Drugs used in essential tremor, chorea, tics, and related disorders"], "cautions": "Cautions\u00a0history of abnormal hepatic function\r\n(consult product literature for details)Blood disorders\u00a0Patients or their\r\ncarers should be told how to recognise signs of neutropenia and advised\r\nto seek immediate medical attention if symptoms such as fever occur; white blood cell counts should be determined in febrile\r\nillness; neutropenia requires discontinuation of riluzoleInterstitial lung disease\u00a0Perform\r\nchest radiography if symptoms such as dry cough or dyspnoea develop; discontinue if interstitial lung disease is diagnosedDriving\u00a0Dizziness or vertigo may\r\naffect performance of skilled tasks (e.g. driving)", "side-effects": "Side-effects\u00a0nausea, vomiting, diarrhoea, abdominal pain; tachycardia;\r\nasthenia, headache, dizziness, drowsiness, oral paraesthesia; less commonly interstitial lung disease, pancreatitis, angioedema,\r\nand anaemia; rarely neutropenia; very rarely hepatitis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/40688.htm", "doses": ["50\u00a0mg twice daily; child not recommended"], "pregnancy": "Pregnancy\u00a0avoid\u2014no information available"}]